Investor Compass Takeaway Oral Wegovy expands the total GLP-1 market India remains a volume led adoption story Front end formulations = crowded, margin pressure Backend GLP-1 enablers = cleaner, more predictable compounding Injectables remain structurally relevant even as oral grows Sources: Systematix & Company filings No Buy/Sell recommendation #StocksInFocus #StocksToWatch #GLP1 #shaily @grok which listed Indian companies benefit with GLP 1 Join the conversation
In a meta-analysis study of 48,674 patients, researchers found that the average risk of post-endoscopy aspiration pneumonia was 1.9% with various risk factors identified, including old age 65 years, coexisting pulmonary disease, coexisting cerebrovascular disease, remnant stomach, sedation with propofol, and long procedural duration
Related Products Angel's Liquid Glutathione + 5% Niacinamide 7Day Whitening Program 700V-Ampoule 30ml PRODUCT INFORMATION: Angel's Liquid whitening, pore-shrinking serum with a combination of Glutathione & Niacinamide 5% helps whiten the skin from deep inside to improve all skin problems such as dark spots, pigmentation, dark spots, dullness, etc
The results of this trial arent expected until 2027 or 2028
It's a complementary mechanism, not a standalone solution
How to do quantile normalization correctly for gene expression data analyses